Express News | Natera: To Redeem $287.5 Mln Convertible Senior Notes Due 2027
Here's How Much You Would Have Made Owning Natera Stock In The Last 5 Years
Express News | Natera Inc : Leerink Partners Raises Target Price to $135 From $130
Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
Natera, Inc.'s (NASDAQ:NTRA) Business Is Yet to Catch Up With Its Share Price
These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird
Optimistic Outlook for Natera's Growth Potential Based on ALTAIR Trial and MRD Market Opportunity
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today
Jefferies Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $142
Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Natera (NTRA) and Argenx Se (ARGX)
Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
Insider Sale: CEO and President Steven Chapman Sells 37,500 Shares of Natera Inc (NTRA)
Natera(NTRA.US) Officer Sells US$4.05 Million in Common Stock
Natera(NTRA.US) Director Sells US$293.94K in Common Stock
Form 144 | Natera(NTRA.US) Officer Proposes to Sell 4.05 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Natera(NTRA.US)$ Officer STEVEN L CHAPMAN intends to sell 37,500 shares of its common stock on Jul 1, with a total market value of approximately $4.05 million. STEVEN
Morgan Stanley Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $125
Positive Outlook for Natera Inc.: Savant Recommends Buy on Strong Study Design and Market Strategy
Cathie Wood's Top and Bottom Performing ARKK Holdings of H1
Natera's New Cancer Trial to Use Signatera for Personalized Treatment
Express News | Natera Announces Decipher: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer